STIEFL; Nikolaus Johannes
Patent Applications and Registrations
Patent applications and USPTO patent grants for STIEFL; Nikolaus Johannes.The latest application filed is for "nlrp3 inflammasome inhibitors".
- STIEFL; Nikolaus Johannes - Lorrach DE
- Stiefl; Nikolaus Johannes - Basel CH
| Patent | Date |
|---|---|
| Nlrp3 Inflammasome Inhibitors App 20220251067 - FARADY; Christopher ; et al. | 2022-08-11 |
| NLRP3 inflammasome inhibitors Grant 11,254,653 - Farady , et al. February 22, 2 | 2022-02-22 |
| NLRP3 inflammasome inhibitors Grant 11,208,399 - Farady , et al. December 28, 2 | 2021-12-28 |
| Pyridinone derivatives and their use as selective ALK-2 inhibitors Grant 11,160,797 - Arista , et al. November 2, 2 | 2021-11-02 |
| Nlrp3 Inflammasome Inhibitors App 20210308140 - FARADY; Christopher ; et al. | 2021-10-07 |
| Aminopyridine Derivatives And Their Use As Selective Alk-2 Inhibitors App 20210155606 - ARISTA; Luca ; et al. | 2021-05-27 |
| Aminopyridine derivatives and their use as selective ALK-2 inhibitors Grant 10,947,218 - Arista , et al. March 16, 2 | 2021-03-16 |
| Nlrp3 Inflammasome Inhibitors App 20200361899 - FARADY; Christopher ; et al. | 2020-11-19 |
| Nlrp3 Inflammasome Inhibitors App 20200361898 - FARADY; Christopher ; et al. | 2020-11-19 |
| Pyridinone derivatives and their use as selective ALK-2 inhibitors App 20200360357 - Arista; Luca ; et al. | 2020-11-19 |
| Aminopyridine Derivatives And Their Use As Selective Alk-2 Inhibitors App 20200299265 - ARISTA; Luca ; et al. | 2020-09-24 |
| Aminopyridine derivatives and their use as selective ALK-2 inhibitors Grant 10,710,980 - Arista , et al. | 2020-07-14 |
| Aminopyridine Derivatives And Their Use As Selective Alk-2 Inhibitors App 20190161474 - ARISTA; Luca ; et al. | 2019-05-30 |
| Imidazo-pyridine derivatives as activin-like receptor kinase (ALK4 or ALK5) inhibitors Grant 9,079,897 - Leblanc , et al. July 14, 2 | 2015-07-14 |
| Aryl benzylamine compounds Grant 8,791,100 - Angst , et al. July 29, 2 | 2014-07-29 |
| Organic compounds Grant 8,431,578 - Hunt , et al. April 30, 2 | 2013-04-30 |
| Organic compounds Grant 8,367,662 - Shaw , et al. February 5, 2 | 2013-02-05 |
| Organic compounds Grant 8,343,966 - Adcock , et al. January 1, 2 | 2013-01-01 |
| Pyrrolopyrimidines and pyrrolopyridines Grant 8,314,112 - Leblanc , et al. November 20, 2 | 2012-11-20 |
| Organic compounds Grant 8,143,253 - Lizos , et al. March 27, 2 | 2012-03-27 |
| Aryl Benzylamine Compounds App 20110190258 - ANGST; Daniela ; et al. | 2011-08-04 |
| Pyrimidine derivatives as alk-5 inhibitors Grant 7,989,458 - Leblanc , et al. August 2, 2 | 2011-08-02 |
| Imidazo-Pyridine Derivatives as Activin-Like Receptor Kinase (ALK4 or ALK5) Inhibitors App 20110060004 - Leblanc; Catherine ; et al. | 2011-03-10 |
| Organic Compounds App 20100298337 - Hunt; Peter ; et al. | 2010-11-25 |
| Organic Compounds App 20100210641 - Shaw; Duncan ; et al. | 2010-08-19 |
| Heterocyclic compounds as antiinflammatory agents App 20100041662 - Ferrand; Sandrine ; et al. | 2010-02-18 |
| Organic compounds App 20090215776 - Adcock; Claire ; et al. | 2009-08-27 |
| Pyrimidine derivatives as alk-5 Inhibitors App 20090209539 - Leblanc; Catherine ; et al. | 2009-08-20 |
| Pyrrolopyrimidines and Pyrrolopyridines App 20090181941 - Leblanc; Catherine ; et al. | 2009-07-16 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 